ICU
SeaStar Medical Holding CorporationNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$15.22M
P/E Ratio
—
EPS
$-5.86
Beta
-1.19
52W High
$13.40
52W Low
$2.07
50-Day MA
$3.13
200-Day MA
$4.81
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation (ICU) is a pioneering biotechnology firm dedicated to advancing therapeutics for chronic kidney disease through its proprietary technologies designed to enhance renal function and reduce the reliance on invasive procedures. Positioned within a substantial and expanding market, SeaStar addresses critical unmet medical needs while focusing on innovation and clinical excellence. With a robust research and development pipeline and strategic partnerships, the company is poised to lead in renal health advancements and accelerate the commercialization of its transformative therapies.
Fundamentals
| Revenue (TTM) | $1.23M |
| Gross Profit (TTM) | $1.18M |
| EBITDA | — |
| Operating Margin | -718.00% |
| Return on Equity | -295.10% |
| Return on Assets | -80.90% |
| Revenue/Share (TTM) | $0.59 |
| Book Value | $2.71 |
| Price-to-Book | 1.58 |
| Price-to-Sales (TTM) | 12.33 |
| EV/Revenue | 4.083 |
| EV/EBITDA | -8.13 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 527.00% |
| Shares Outstanding | $3.99M |
| Float | $3.95M |
| % Insiders | 2.40% |
| % Institutions | 6.10% |
Historical Volatility
HV 10-Day
97.18%
HV 20-Day
128.07%
HV 30-Day
144.62%
HV 60-Day
110.98%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($9.00 target)
1
Strong BuyData last updated: 4/28/2026